| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Pharmacology Branch [M. V. B., T. S., L. M. N.] and Medicine Branch [P. N., J. T.], National Cancer Institute, NIH, Bethesda, Maryland 20892
c-Raf-1 (Raf-1) is a central component of signal transduction pathways stimulated by various growth factors, protein kinase C, and other protein kinases. Raf-1 activation is thought to be initiated at the plasma membrane after its recruitment by Ras. Raf-1 activation is associated primarily with proliferation and cell survival, but it has also been implicated in apoptosis. Raf-1 has also been shown to form complexes with both R-Ras and Bcl-2, raising the possibility that this component of cellular Raf-1 plays a role in apoptosis. Recently, taxol was reported to induce Bcl-2 phosphorylation and inactivation. We have previously demonstrated Raf-1 activation following taxol in MCF7 cells. We now present evidence that taxol fails to stimulate either apoptosis or phosphorylation of Bcl-2 in the absence of Raf-1. Moreover, Raf-1 activation by taxol coincided with Bcl-2 phosphorylation, showing similar dose and time dependence. Thus, our data support a role for a distinct subcellular component of Raf-1, which is taxol but not phorbol myristate acetate sensitive, in mediating an apoptotic pathway involving Bcl-2.
1 Present address: University of Pennsylvania School of Medicine, Department of Hematology and Oncology, 437 CRB, 415 Curia Boulevard, Philadelphia, PA 19104.
2 To whom requests for reprints should be addressed, at Clinical Pharmacology Branch, National Cancer Institute, NIH, Building 10, 12N226, Bethesda, MD 20892.
Received 11/ 3/95. Accepted 3/ 4/96.
This article has been cited by other articles:
|
|
 |
|
  Y.-M. Fu and G. G. Meadows Specific Amino Acid Dependency Regulates the Cellular Behavior of Melanoma J. Nutr., June 1, 2007; 137(6): 1591S - 1596S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Skobeleva, S. Menon, L. Weber, E. A. Golemis, and V. Khazak In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors Mol. Cancer Ther., March 1, 2007; 6(3): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Vijapurkar, W. Wang, and R. Herbst Potentiation of Kinesin Spindle Protein Inhibitor-Induced Cell Death by Modulation of Mitochondrial and Death Receptor Apoptotic Pathways Cancer Res., January 1, 2007; 67(1): 237 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. De Chiara, M. E. Marcocci, M. Torcia, M. Lucibello, P. Rosini, P. Bonini, Y. Higashimoto, G. Damonte, A. Armirotti, S. Amodei, et al. Bcl-2 Phosphorylation by p38 MAPK: IDENTIFICATION OF TARGET SITES AND BIOLOGIC CONSEQUENCES J. Biol. Chem., July 28, 2006; 281(30): 21353 - 21361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Russo, P. G. Magro, Z. Hu, W.-W. Li, R. Peters, J. Mandola, D. Banerjee, and J. R. Bertino E2F-1 Overexpression in U2OS Cells Increases Cyclin B1 Levels and cdc2 Kinase Activity and Sensitizes Cells to Antimitotic Agents. Cancer Res., July 15, 2006; 66(14): 7253 - 7260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hosono, T. Fukao, J. Ogihara, Y. Ito, H. Shiba, T. Seki, and T. Ariga Diallyl Trisulfide Suppresses the Proliferation and Induces Apoptosis of Human Colon Cancer Cells through Oxidative Modification of {beta}-Tubulin J. Biol. Chem., December 16, 2005; 280(50): 41487 - 41493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kondo, T. Miyake, M. Shibata, T. Kimura, H. Iwagaki, S.-i. Nakamura, T. Tanaka, N. Ohara, K. Ichimura, T. Oka, et al. Expression of Phosphorylated Ser70 of Bcl-2 Correlates with Malignancy in Human Colorectal Neoplasms Clin. Cancer Res., October 15, 2005; 11(20): 7255 - 7263. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-H. Liao, S.-L. Pan, J.-H. Guh, Y.-L. Chang, H.-C. Pai, C.-H. Lin, and C.-M. Teng Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo Carcinogenesis, May 1, 2005; 26(5): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kikuno, N. Moriyama-Gonda, T. Yoshino, T. Yoneda, S. Urakami, M. Terashima, M. Yoshida, H. Kishi, K. Shigeno, H. Shiina, et al. Blockade of Paclitaxel-Induced Thymidine Phosphorylase Expression Can Accelerate Apoptosis in Human Prostate Cancer Cells Cancer Res., October 15, 2004; 64(20): 7526 - 7532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Pushkarev, D. V. Starenki, V. A. Saenko, H. Namba, J. Kurebayashi, M. D. Tronko, and S. Yamashita Molecular Mechanisms of the Effects of Low Concentrations of Taxol in Anaplastic Thyroid Cancer Cells Endocrinology, July 1, 2004; 145(7): 3143 - 3152. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Cheung, M.-t. Ling, S. W. Tsao, Y.C. Wong, and X. Wang Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells Carcinogenesis, June 1, 2004; 25(6): 881 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Wang, A. A. Davis, D. G. Culver, Q. Wang, J. C. Powers, and J. D. Glass Calpain inhibition protects against Taxol-induced sensory neuropathy Brain, March 1, 2004; 127(3): 671 - 679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mabuchi, M. Ohmichi, A. Kimura, Y. Nishio, E. Arimoto-Ishida, N. Yada-Hashimoto, K. Tasaka, and Y. Murata Estrogen Inhibits Paclitaxel-Induced Apoptosis via the Phosphorylation of Apoptosis Signal-Regulating Kinase 1 in Human Ovarian Cancer Cell Lines Endocrinology, January 1, 2004; 145(1): 49 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cohen-Saidon, H. Nechushtan, S. Kahlon, N. Livni, A. Nissim, and E. Razin A novel strategy using single-chain antibody to show the importance of Bcl-2 in mast cell survival Blood, October 1, 2003; 102(7): 2506 - 2512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, M. Bally, W. H. Dragowska, and L. Mayer Inhibition of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Enhances Chemotherapeutic Effects on H460 Human Non-Small Cell Lung Cancer Cells through Activation of Apoptosis Mol. Cancer Ther., July 1, 2003; 2(7): 641 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Gandara, K. Chansky, K. S. Albain, B. R. Leigh, L. E. Gaspar, P. N. Lara Jr, H. Burris, P. Gumerlock, J. P. Kuebler, J. D. Bearden III, et al. Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non-Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504 J. Clin. Oncol., May 15, 2003; 21(10): 2004 - 2010. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Davis, P. M. Navolanic, C. R. Weinstein-Oppenheimer, L. S. Steelman, W. Hu, M. Konopleva, M. V. Blagosklonny, and J. A. McCubrey Raf-1 and Bcl-2 Induce Distinct and Common Pathways That Contribute to Breast Cancer Drug Resistance Clin. Cancer Res., March 1, 2003; 9(3): 1161 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-H. Ling, J.-D. Jiang, J. F. Holland, and R. Perez-Soler Arsenic Trioxide Produces Polymerization of Microtubules and Mitotic Arrest before Apoptosis in Human Tumor Cell Lines Mol. Pharmacol., September 1, 2002; 62(3): 529 - 538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mabuchi, M. Ohmichi, A. Kimura, K. Hisamoto, J. Hayakawa, Y. Nishio, K. Adachi, K. Takahashi, E. Arimoto-Ishida, Y. Nakatsuji, et al. Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel J. Biol. Chem., August 30, 2002; 277(36): 33490 - 33500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. MacKeigan, D. J. Taxman, D. Hunter, H. S. Earp III, L. M. Graves, and J. P-Y. Ting Inactivation of the Antiapoptotic Phosphatidylinositol 3-Kinase-Akt Pathway by the Combined Treatment of Taxol and Mitogen-activated Protein Kinase Kinase Inhibition Clin. Cancer Res., July 1, 2002; 8(7): 2091 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Van Poznak, L. Tan, K. S. Panageas, C. D. Arroyo, C. Hudis, L. Norton, and A. D. Seidman Assessment of Molecular Markers of Clinical Sensitivity to Single-Agent Taxane Therapy for Metastatic Breast Cancer J. Clin. Oncol., May 1, 2002; 20(9): 2319 - 2326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jankala, C. J. P. Eriksson, K. K. Eklund, M. Harkonen, and T. Maki COMBINED CALCIUM CARBIMIDE AND ETHANOL TREATMENT INDUCES HIGH BLOOD ACETALDEHYDE LEVELS, MYOCARDIAL APOPTOSIS AND ALTERED EXPRESSION OF APOPTOSIS-REGULATING GENES IN RAT Alcohol Alcohol., May 1, 2002; 37(3): 222 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Barrett, F. L. Lewis, J. B. Roaten, T. W. Sweatman, M. Israel, J. L. Cleveland, and L. Lothstein Novel Extranuclear-targeted Anthracyclines Override the Antiapoptotic Functions of Bcl-2 and Target Protein Kinase C Pathways to Induce Apoptosis Mol. Cancer Ther., May 1, 2002; 1(7): 469 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rajah, K.-W. Lee, and P. Cohen Insulin-like Growth Factor Binding Protein-3 Mediates Tumor Necrosis Factor-{alpha}-induced Apoptosis: Role of Bcl-2 Phosphorylation Cell Growth Differ., April 1, 2002; 13(4): 163 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Del Bufalo, V. Di Castro, A. Biroccio, M. Varmi, D. Salani, L. Rosano, D. Trisciuoglio, F. Spinella, and A. Bagnato Endothelin-1 Protects Ovarian Carcinoma Cells against Paclitaxel-Induced Apoptosis: Requirement for Akt Activation Mol. Pharmacol., March 1, 2002; 61(3): 524 - 532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Konopleva, T. Tsao, P. Ruvolo, I. Stiouf, Z. Estrov, C. E. Leysath, S. Zhao, D. Harris, S. Chang, C. E. Jackson, et al. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia Blood, January 1, 2002; 99(1): 326 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ye, J. Zhou, J. W. Landen, E. M. Bradbury, and H. C. Joshi Sustained Activation of p34cdc2 Is Required for Noscapine-induced Apoptosis J. Biol. Chem., December 7, 2001; 276(50): 46697 - 46700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. A. Figueroa-Masot, M. Hetman, M. J. Higgins, N. Kokot, and Z. Xia Taxol Induces Apoptosis in Cortical Neurons by a Mechanism Independent of Bcl-2 Phosphorylation J. Neurosci., July 1, 2001; 21(13): 4657 - 4667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Dent and S. Grant Pharmacologic Interruption of the Mitogen-activated Extracellular-regulated Kinase/Mitogen-activated Protein Kinase Signal Transduction Pathway: Potential Role in PromotingCytotoxic Drug Action Clin. Cancer Res., April 1, 2001; 7(4): 775 - 783. [Full Text]
|
|
|
|
|
|
J. A. Vrana and S. Grant Synergistic induction of apoptosis in human leukemia cells (U937) exposed to bryostatin 1 and the proteasome inhibitor lactacystin involves dysregulation of the PKC/MAPK cascade Blood, April 1, 2001; 97(7): 2105 - 2114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lee and Y. J. Jeon Paclitaxel-Induced Immune Suppression Is Associated with NF-{kappa}B Activation Via Conventional PKC Isotypes in Lipopolysaccharide-Stimulated 70Z/3 Pre-B Lymphocyte Tumor Cells Mol. Pharmacol., February 1, 2001; 59(2): 248 - 253. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. Ryan and B. A. Chabner On Receptor Inhibitors and Chemotherapy Clin. Cancer Res., December 1, 2000; 6(12): 4607 - 4609. [Full Text]
|
|
|
|
|
|
K. Inoue, J. W. Slaton, P. Perrotte, D. W. Davis, C. J. Bruns, D. J. Hicklin, D. J. McConkey, P. Sweeney, R. Radinsky, and C. P. N. Dinney Paclitaxel Enhances the Effects of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody ImClone C225 in Mice with Metastatic Human Bladder Transitional Cell Carcinoma Clin. Cancer Res., December 1, 2000; 6(12): 4874 - 4884. [Abstract] [Full Text]
|
|
|
|
|
|
S. Zeng, Y. Z. Chen, L. Fu, K. R. Johnson, and W. Fan In Vitro Evaluation of Schedule-dependent Interactions between Docetaxel and Doxorubicin against Human Breast and Ovarian Cancer Cells Clin. Cancer Res., September 1, 2000; 6(9): 3766 - 3773. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Sgadari, E. Toschi, C. Palladino, G. Barillari, D. Carlei, A. Cereseto, C. Ciccolella, R. Yarchoan, P. Monini, M. Sturzl, et al. Mechanism of Paclitaxel Activity in Kaposi's Sarcoma J. Immunol., July 1, 2000; 165(1): 509 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Wang, W. Yang, M. S. Uytingco, S. Christakos, and R. Wieder 1,25-Dihydroxyvitamin D3 and All-trans-Retinoic Acid Sensitize Breast Cancer Cells to Chemotherapy-induced Cell Death Cancer Res., April 1, 2000; 60(7): 2040 - 2048. [Abstract] [Full Text]
|
|
|
|
|
|
V. A. Miller, L. M. Krug, K. K. Ng, B. Pizzo, W. Perez, R. T. Heelan, and M. G. Kris Phase II Trial of Docetaxel and Vinorelbine in Patients With Advanced Non-Small-Cell Lung Cancer J. Clin. Oncol., March 13, 2000; 18(6): 1346 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. T. Ueno, C. Bartholomeusz, J. L. Herrmann, Z. Estrov, R. Shao, M. Andreeff, J. Price, R. W. Paul, P. Anklesaria, D. Yu, et al. E1A-mediated Paclitaxel Sensitization in HER-2/neu-overexpressing Ovarian Cancer SKOV3.ip1 through Apoptosis Involving the Caspase-3 Pathway Clin. Cancer Res., January 1, 2000; 6(1): 250 - 259. [Abstract] [Full Text]
|
|
|
|
|
|
E. Harper, W. Dang, R. G. Lapidus, and R. I. Garver Jr. Enhanced Efficacy of a Novel Controlled Release Paclitaxel Formulation (PACLIMER Delivery System) for Local-Regional Therapy of Lung Cancer Tumor Nodules in Mice Clin. Cancer Res., December 1, 1999; 5(12): 4242 - 4248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Trail, D. Willner, A. B. Bianchi, A. J. Henderson, M. D. TrailSmith, E. Girit, S. Lasch, I. Hellstrom, and K. E. Hellstrom Enhanced Antitumor Activity of Paclitaxel in Combination with the Anticarcinoma Immunoconjugate BR96-Doxorubicin Clin. Cancer Res., November 1, 1999; 5(11): 3632 - 3638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-J. Zhang, I. Kimijima, M. Onda, M. Kanno, H. Sato, T. Watanabe, A. Tsuchiya, R. Abe, and S. Takenoshita Tamoxifen-induced Apoptosis in Breast Cancer Cells Relates to Down-Regulation of bcl-2, but not bax and bcl-XL, without Alteration of p53 Protein Levels Clin. Cancer Res., October 1, 1999; 5(10): 2971 - 2977. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Theodoropoulos, H. Polioudaki, O. Kostaki, S. P. Derdas, V. Georgoulias, C. Dargemont, and S. D. Georgatos Taxol Affects Nuclear Lamina and Pore Complex Organization and Inhibits Import of Karyophilic Proteins into the Cell Nucleus Cancer Res., September 1, 1999; 59(18): 4625 - 4633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R. Johnson, K. K. Young, and W. Fan Antagonistic Interplay between Antimitotic and G1-S Arresting Agents Observed in Experimental Combination Therapy Clin. Cancer Res., September 1, 1999; 5(9): 2559 - 2565. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kurdoglu, N. Cheong, J. Guan, B. W. Corn, W. J. Curran Jr., and G. Iliakis Apoptosis as a Predictor of Paclitaxel-induced Radiosensitization in Human Tumor Cell Lines Clin. Cancer Res., September 1, 1999; 5(9): 2580 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Navarro, A. M. Valverde, M. Benito, and M. Lorenzo Activated Ha-ras Induces Apoptosis by Association with Phosphorylated Bcl-2 in a Mitogen-activated Protein Kinase-independent Manner J. Biol. Chem., July 2, 1999; 274(27): 18857 - 18863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Eggstein, M Franke, I Kutschka, G Manthey, B U von Specht, G Ruf, and E H Farthmann Expression and activity of mitogen activated protein kinases in human colorectal carcinoma Gut, June 1, 1999; 44(6): 834 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. Tseng, M. S. Bobola, M. S. Berger, and J. R. Silber Characterization of paclitaxel (Taxol(R)) sensitivity in human glioma- and medulloblastoma-derived cell lines Neuro-oncol, April 1, 1999; 1(2): 101 - 108. [Abstract] [PDF]
|
|
|
|
 |
|
 A.-M. C. Yvon, P. Wadsworth, and M. A. Jordan Taxol Suppresses Dynamics of Individual Microtubules in Living Human Tumor Cells Mol. Biol. Cell, April 1, 1999; 10(4): 947 - 959. [Abstract] [Full Text]
|
|
|
|
|
|
J. M. Coco Martin, A. Balkenende, T. Verschoor, F. Lallemand, and R. Michalides Cyclin D1 Overexpression Enhances Radiation-induced Apoptosis and Radiosensitivity in a Breast Tumor Cell Line Cancer Res., March 1, 1999; 59(5): 1134 - 1140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Poommipanit, B. Chen, and Z. N. Oltvai Interleukin-3 Induces the Phosphorylation of a Distinct Fraction of Bcl-2 J. Biol. Chem., January 8, 1999; 274(2): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Liu, T.-Y. Han, A. E. Giuliano, and M. C. Cabot Expression of Glucosylceramide Synthase, Converting Ceramide to Glucosylceramide, Confers Adriamycin Resistance in Human Breast Cancer Cells J. Biol. Chem., January 8, 1999; 274(2): 1140 - 1146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sanders and S. S. Thorgeirsson Phenobarbital promotes liver growth in c-myc/TGF-{alpha} transgenic mice by inducing hypertrophy and inhibiting apoptosis Carcinogenesis, January 1, 1999; 20(1): 41 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. McDaid and P. G. Johnston Synergistic Interaction between Paclitaxel and 8-Chloro-adenosine 3',5'-Monophosphate in Human Ovarian Carcinoma Cell Lines Clin. Cancer Res., January 1, 1999; 5(1): 215 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Sonee, E. Barron, F. A. Yarber, and S. F. Hamm-Alvarez Taxol inhibits endosomal-lysosomal membrane trafficking at two distinct steps in CV-1 cells Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1630 - C1639. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Scatena, Z. A. Stewart, D. Mays, L. J. Tang, C. J. Keefer, S. D. Leach, and J. A. Pietenpol Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest J. Biol. Chem., November 13, 1998; 273(46): 30777 - 30784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. HAMM-ALVAREZ and M. P. SHEETZ Microtubule-Dependent Vesicle Transport: Modulation of Channel and Transporter Activity in Liver and Kidney Physiol Rev, October 1, 1998; 78(4): 1109 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.-B. Hu, M.D. Minden, and E.A. McCulloch Phosphorylation of BCL-2 After Exposure of Human Leukemic Cells to Retinoic Acid Blood, September 1, 1998; 92(5): 1768 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-H. Ling, C. Tornos, and R. Perez-Soler Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis J. Biol. Chem., July 24, 1998; 273(30): 18984 - 18991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zhou, S. D. Demo, T. N. McClure, R. Crea, and C. M. Bitler A Novel Splice Variant of the Cell Death-promoting Protein BAX J. Biol. Chem., May 8, 1998; 273(19): 11930 - 11936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Silvy, P.-M. Martin, N. Chajry, and Y. Berthois Differential Dose-Dependent Effects of Epidermal Growth Factor on Gene Expression in A431 Cells: Evidence for a Signal Transduction Pathway That Can Bypass Raf-1 Activation Endocrinology, May 1, 1998; 139(5): 2382 - 2391. [Abstract] [Full Text] [PDF]
|
|
